Head-to-head · WeighScore
Center for Medical Weight Loss (CMWL) vs TRYM Health
By GLP-1 ScorecardUpdated
Score comparison
TRYM Health has the higher recorded score — 70.6/100 to 66.9/100.
TRYM Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose vials covering all doses, with a starter kit, temperature-controlled shipping, FSA/HSA eligibility, and flexible cancellation.
Before you choose
Before comparing the headline prices, the Center for Medical Weight Loss (CMWL) review and the TRYM Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Auren Rx vs Center for Medical Weight Loss (CMWL) and CoraDoc vs TRYM Health compare each of them with another graded program, and the list of alternatives to Center for Medical Weight Loss (CMWL) ranks the programs closest to Center for Medical Weight Loss (CMWL) on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Center for Medical Weight Loss (CMWL) | TRYM Health |
|---|---|---|
| WeighScore | 66.9/100 | 70.6/100 |
| Grade | C | C |
| Site position | #187 | #114 |
| Semaglutide | $99/mo on monthly billing; $816 billed yearly at the $68/mo equivalent | $96/mo (all doses, compounded) |
| Tirzepatide | $149/mo on monthly billing; $1,416 billed yearly at the $118/mo equivalent | $126/mo (all doses, compounded) |
| Coverage | Confirm eligibility for the selected treatment | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Product pages show separate term totals and renewal intervals
- Refund policy distinguishes ineligibility from cancellation after submission for review
What to consider
- Lowest advertised monthly equivalents require annual payment
- Two-month supply plans renew every seven weeks
- Ask which dispensing pharmacy and refund terms apply to the selected order
FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.
Strengths
- Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
- Available in all 50 states with free shipping and FSA/HSA eligibility
- Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
- Temperature-controlled insulated shipping and flexible cancellation
What to consider
- Compounding pharmacy partner not named
- LegitScript certification was not documented on the public pages reviewed
- Lowest per-day pricing likely requires a longer prepaid plan commitment
- Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
- FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.